Sellas Life Sciences: 'Hold' As Phase 3 AML Study Progresses To Key Event

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

NFL draft: Biggest questions of the first round, including if Alabama QB Ty Simpson will be picked

Will Alabama quarterback Ty Simpson go in the first round? We answer that and more ahead of Thursday's NFL draft.

It’s quiet now in this border town, but challenges linger in the aftermath of the migrant surge

Yuma, a border town in Arizona, is still reeling after four years of unprecedented migrant crossings.

The AI Paradox: Why World-Class Algorithms Fail On Second-Class Data

In 2026, tech leaders are learning a painful lesson: the problem with scaling AI adoption isn't understanding the algorithm, ...